154 related articles for article (PubMed ID: 1834063)
1. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunosuppressive properties of cyclosporine metabolites.
Freed BM; Rosano TG; Lempert N
Transplantation; 1987 Jan; 43(1):123-7. PubMed ID: 2948307
[TBL] [Abstract][Full Text] [Related]
3. Additive and synergistic effects of cyclosporine metabolites on glomerular mesangial cells.
Radeke HH; Christians U; Bleck JS; Sewing KF; Resch K
Kidney Int; 1991 Jun; 39(6):1255-66. PubMed ID: 1895678
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive metabolites of cyclosporine in the blood of renal allograft recipients.
Rosano TG; Freed BM; Cerilli J; Lempert N
Transplantation; 1986 Sep; 42(3):262-7. PubMed ID: 2944258
[TBL] [Abstract][Full Text] [Related]
5. Anti-allergic activity of cyclosporin-A metabolites and their interaction with the parent compound and FK 506.
Ezeamuzie CI
Int J Immunopharmacol; 1996 Apr; 18(4):263-70. PubMed ID: 8894806
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
Sadeg N; Pham-Huy C; Rucay P; Righenzi S; Halle-Pannenko O; Claude JR; Bismuth H; Duc HT
Immunopharmacol Immunotoxicol; 1993; 15(2-3):163-77. PubMed ID: 8349948
[TBL] [Abstract][Full Text] [Related]
7. The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis.
Woo J; Sewell HF; Thomson AW
Scand J Immunol; 1990 Mar; 31(3):297-304. PubMed ID: 1690915
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
Rayat G; Yatscoff R; Silverman R; McKenna R
Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effect of cyclosporine on the nuclear proliferative response to a variety of T cell activators.
Citterio F; Kahan BD
Transplantation; 1989 Feb; 47(2):334-8. PubMed ID: 2521963
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation.
Vathsala A; Chou TC; Kahan BD
Transplantation; 1990 Feb; 49(2):463-72. PubMed ID: 1689520
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
Chabannes D; Moreau JF; Soulillou JP
Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
[TBL] [Abstract][Full Text] [Related]
12. Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine A on human T lymphocyte alloproliferative response in vitro.
Schanz U; Hügle T; Gmür J
Transplantation; 1996 Jun; 61(12):1736-40. PubMed ID: 8685953
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclosporine metabolites M17 and M18 on proliferation and interleukin 2 production in the mixed lymphocyte culture.
Freed BM; Rosano TG; Quick C; Lempert N
Transplant Proc; 1987 Feb; 19(1 Pt 2):1223-6. PubMed ID: 2950629
[No Abstract] [Full Text] [Related]
14. The cyclosporins inhibit lymphocyte activation at more than one site.
Gelfand EW; Cheung RK; Mills GB
J Immunol; 1987 Feb; 138(4):1115-20. PubMed ID: 3492542
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis.
Stio M; Treves C; Celli A; Tarantino O; d'Albasio G; Bonanomi AG
Am J Gastroenterol; 2002 Mar; 97(3):679-89. PubMed ID: 11922564
[TBL] [Abstract][Full Text] [Related]
16. Additive effects of calcium antagonists on cyclosporin A-induced inhibition of T-cell proliferation.
Marx M; Weber M; Merkel F; Meyer zum Büschenfelde KH; Köhler H
Nephrol Dial Transplant; 1990; 5(12):1038-44. PubMed ID: 2151399
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
Transplant Proc; 1987 Oct; 19(5 Suppl 6):40-4. PubMed ID: 2445073
[No Abstract] [Full Text] [Related]
18. Gender-related assessment of cyclosporine/prednisolone/sirolimus interactions in three human lymphocyte proliferation assays.
Ferron GM; Pyszczynski NA; Jusko WJ
Transplantation; 1998 May; 65(9):1203-9. PubMed ID: 9603169
[TBL] [Abstract][Full Text] [Related]
19. The hydroxylamine of sulfamethoxazole synergizes with FK506 and cyclosporin A, inhibiting T-cell proliferation.
Hess DA; Bird IA; Almawi WY; Rieder MJ
J Pharmacol Exp Ther; 1997 Apr; 281(1):540-8. PubMed ID: 9103542
[TBL] [Abstract][Full Text] [Related]
20. The immunosuppressive antagonism of low doses of FK506 and cyclosporine.
Vathsala A; Goto S; Yoshimura N; Stepkowski S; Chou TC; Kahan BD
Transplantation; 1991 Jul; 52(1):121-8. PubMed ID: 1713361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
